Stay updated on PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial

Sign up to get notified when there's something new on the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a modification in the dosage of the study drug PF-06480605 for the treatment of adults with moderate to severe ulcerative colitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:01.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' which includes details on general health conditions and prior treatments required for study eligibility.
    Difference
    9%
    Check dated 2024-05-22T20:54:19.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:48:36.000Z thumbnail image

Stay in the know with updates to PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page.